Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol

Journal of Neuroscience

Volumn 18, Issue 14, 1998, Pages 5322-5332

  Chan, Guy Chiu Kai ^a   Hinds, Thomas R ^a   Impey, Soren ^a   Storm, Daniel R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Cannabinoid receptors; CB1; Cell death; Hippocampal neurons; Reactive oxygen species; SR141716A; THC

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; CANNABIS; DRONABINOL; FREE RADICAL; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTANOID; REACTIVE OXYGEN METABOLITE; RIMONABANT; ADENYLATE CYCLASE; CALCIUM; NEUROTOXIN; PHOSPHOLIPASE A; TETRAHYDROCANNABINOL;

AMNESIA; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANNABIS ADDICTION; CONTROLLED STUDY; HIPPOCAMPUS; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; ANIMAL; CELL CULTURE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; IN VITRO STUDY; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ADENYLATE CYCLASE; ANIMALS; ARACHIDONIC ACID; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; HIPPOCAMPUS; NEURONS; NEUROTOXINS; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROCANNABINOL; VITAMIN E;

EID: 0032527129     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-14-05322.1998     Document Type: Article

References (89)

1. Abel EL (1970) Marijuana and memory. Nature 227:1151-1152.
2. Abel EL (1971) Retrieval of information after use of marijuana. Nature 231:58.
3. Abood ME, Martin BR (1992) Neurobiology of marijuana abuse. Trends Pharmacol Sci 13:201-206.
4. Audette CA, Burstein SH, Doyle SA, Hunter SA (1991) G-protein mediation of cannabinoid-induced phospholipasc activation. Pharmacol Biochem Behav 40:559-563.
5. Baeuerle PA, Baltimore D (1996) NF-κB: ten years after. Cell 87:13-20.
6. Block RI, Ghoneim MM (1993) Effects of chronic marijuana use on human cognition. Psychopharmacology 110:219-228.
7. Bottenstein JE, Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 70:514-519.
8. Bouaboula M, Bourrie B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P (1995) Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 270:13973-13980.
9. Brewer GJ, Torricelli JR, Evege EK, Price PJ (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35:567-576.
10. Carlini EA, Hamaoui A, Bienick D, Korte F (1970) Effects of (-) delta-9-trans-tetrahydrocannabinol and a synthetic derivative on maze performance of rats. Pharmacology 4:359-368.
11. Chavez Noriega LE, Stevens CF (1994) Increased transmitter release at excitatory synapses produced by direct activation of adenylate cyclase in rat hippocampal slices. J Neurosci 14:310-317.
12. Chen Q, Galleano M, Cederbaum AI (1997) Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. J Biol Chem 272:14532-14541.
13. Chiang CWN, Barnett G (1984) Marijuana effect and delta-9-tetrahydrocannabinol plasma level. Clin Pharmacol Ther 36:234-238.
14. Collins DR, Pertwee RG, Davies SN (1994) The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur J Pharmacol 259:R7-R8.
15. Croxtall JD, Choudhury Q, Tokumoto H, Flower RJ (1995)
16. 2 activity. Biochem Pharmacol 50:465-474.
17. 9-tetrahydrocannabinol is mediated by nuclear factor κB and CB1 cannabinoid receptor. DNA Cell Biol 16:301-309.
18. Damasio AR, Eslinger PJ, Damasio H, Van Hoesen GW, Cornell S (1985) Multimodal amnesic syndrome following bilateral temporal and basal forebrain damage. Arch Neurol 42:252-259.
19. Deckwerth TL, Johnson Jr EM (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol 123:1207-1222.
20. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
21. Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151-178.
22. Fehr KA, Kalant H, LeBlanc AE (1976) Residual learning deficit after heavy exposure to cannabis or alcohol in rats. Science 192:1249-1251.
23. Fletcher JM, Page JB, Francis DJ, Cope-hind K, Naus MJ, Davis CM, Morris R, Krauskopf D, Satz P (1996) Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry 53:1051-1057.
24. Flowers J (1988) Lipocortin and the mechanism of action of the glueoeorticoids. Br J Pharmacol 94:987-1015.
25. Frey U, Huang YY, Kandel ER (1993) Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260:1661-1664.
26. Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P (1990) The induction and suppression of prostaglandin H2 synthase (cydooxygenase) in human monocytes. J Biol Chem 265:16737-16740.
27. Furukawa K, Estus S, Fu W, Mark RJ, Mattson MP (1997) Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways. J Cell Biol 136:1137-1149.
28. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
29. Greenlund LJS, Deckwerth TL, Johnson Jr EM (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14:303-315.
30. Jaffe JH (1990) Drug addiction and drug abuse. In: Goodman and Gilman's pharmacological basis of therapeutics, Eighth Edition (Gilman AG, Rall TW, Nies AS, Taylor P, eds), pp 522-573. New York: Pergamon.
31. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210.
32. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
33. Hockenbery D (1995) Defining apoptosis. Am J Pathol 146:16-19.
34. Holcomb JD, Mumm JS, Calof AL (1995) Apoptosis in the neuronal lineage of the mouse olfactory epithelium: regulation in vivo and in vitro, Dev Biol 172:307-323.
35. Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38:1-20.
36. Hewlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634.
37. Howlett AC, Fleming RM (1984) Cannabinoid inhibition of adenylate cyclase. Mol Pharmacol 26:532-538.
38. Howlett AC, Qualy JM, Khachatrian L (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimctic drugs. Mol Pharmacol 29:307-313.
39. Impey S, Mark M, Villacres EC, Poser S, Chavkin C, Storm DR (1996) Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron 16:973-982.
40. Kuehl FA, Egan RW (1980) Prostaglandins, arachidonic acid, and inflammation. Science 210:978-984.
41. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J (1993) NMDA-dependent Superoxide production and neurotoxicity. Nature 364:535-537.
42. Landtield PW, Cadwallader LB, Vinsant S (1988) Quantitative changes in hippocampal structure following long-term exposure to THC: possible mediation by glucocorticoid systems. Brain Res 443:47-62.
43. Li Y, Maher P, Schubert D (1997) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19:453-463.
44. Lichtman AH, Dimen KR, Martin BR (1995) Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119:282-290.
45. Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
46. Mackie K, Devane WA, Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44:498-503.
47. Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 146:3-15.
48. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
49. McConkey DJ, Orrenius S (1996) The role of calcium in the regulation of apoptosis. J Leukoc Biol 59:775-783.
50. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA (1996) Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16:1337-1345.
51. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
52. Nobes CD, Tolkovsky AM (1995) Neutralizing anti-p21 ras Fabs suppress rat sympathetic neuron survival induced by NGF, LIF, CNTF and cAMP. Eur J Neurosci 7:344-350.
53. Nowicky AV, Teyler TJ, Vardaris RM (1987) The modulation of longterm potentiation by delta-9-tetrahydrocannabino! in the rat hippocampus, in vitro. Brain Res Bull 19:663-672.
54. Olton DS (1987) The radial arm maze as a tool in behavioral pharmacology. Physiol Behav 40:793-797.
55. Otsuki H, Yamada K, Yuguchi T, Taneda M, Hayakawa T (1994) Prostaglandin E1 induces c-Fos and Myc proteins and protects rat hippocampal cells against hypoxic injury. J Cereb Blood Flow Metab 14:150-155.
56. Perez-Reyes M, Burstein SH, White WR, McDonald SA, Hicks RE (1991) Antagonism of marijuana effects by indomethacin in humans. Life Sci 48:507-515.
57. Pope HG, Yurgelun-Todd D (1996) The residual cognitive effects of heavy marijuana use in college students. J Am Med Assoc 275:521-527.
58. Pourcyrous M, Leffler CW, Mirro R, Busija DW (1990) Brain superoxide anion generation during asphyxia and reventilation in newborn pigs. Pediatr Res 28:618-621.
59. Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, Felder CC (1995) Mead ethanolamidc, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Mol Pharmacol 48:288-292.
60. Reichman M, Nen W, Hokin LE (1987) Effects of delta-9-tetrahydrocannabinol on prostaglandin formation in brain. Mol Pharmacol 32:686-690.
61. Reichman M, Nen W, Hokin LE (1988) Delta-9-tetrahydrocannabinol increases arachidonate levels in guinea pig cerebral cortex slices. Mol Pharmacol 34:823-828.
62. Reichman M, Nen W, Hokin LE (1991) Delta 9-tetrahydrocannabinol inhibits arachidonic acid acylation of phospholipids and triacylglycerols in guinea pig cerebral cortex slices. Mol Pharmacol 40:547-555.
63. Reisinc T, Brownstein MJ (1994) Opioid and cannahinoid receptors. Curr Opin Neurobiol 4:406-412.
64. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Breliere JC, Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
65. Seallet AC (1991) Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals. Pharmacol Biochem Behav 40:671-676.
66. Seallet AC, Uemura E, Andrews A, Ali SF, McMillan DE, Paule MG, Brown RM, and Slikker Jr W (1987) Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC). Brain Res 436:193-198.
67. Schwartz RH, Gruenewald PJ, Klitzner M, Fedio P (1989) Short-term memory impairment in cannabis-dependent adolescents. Am J Dis Child 143:1214-1219.
68. Scoville WB, Milner B (1957) Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 20:11-21.
69. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
70. Shivachar AC, Martin BR, Ellis EF (1996) Anandamide- and delta-9-tetrahydrocannabinol-evoked arachidonic aid mobilization and blockade by SR141716A. Biochem Pharmacol 51:669-676.
71. Simonian NA, Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83-106.
72. Stiglick A, Kalant H (1982a) Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats, Psychopharmacology 77:117-123.
73. Stiglick A, Kalant H (1982b) Residual effects of prolonged cannabis administration on exploration and DRL performance in rats. Psychopharmacology 77:124-128.
74. Stiglick A, Kalant H (1983) Behavioral effects of prolonged administration of delta 9-tetrahydrocannabinol in the rat. Psychopharmacology 80:325-330.
75. Stiglick A, Llewellyn ME, Kalant H (1984) Residual effects of prolonged cannabis treatment on shuttle-box avoidance in the rat. Psychopharmacology 84:476-479.
76. 2+ in neuroblastoma x glioma hybrid NG108-15 cells. Biochem Biophys Res Commun 229:58-64.
77. Takeshima T, Johnston JM, Commissiong JW (1994) Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci 14:4769-4779.
78. Tang DG, Chen YQ, Honn KV (1996) Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc Natl Acad Sci USA 93:5241-5246.
79. Thomas BF, Compton DR, Martin BR (1990) Characterization of the lipophilicity of natural and synthetic analogs of delta-9-THC and its relationship to pharmacological potency. J Pharmacol Exp Ther 255:624-630.
80. Troy CM, Shelanski ML (1994) Down-regulation of copper/zinc super-oxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci USA 91:6384-6387.
81. Trump BF, Berezesky IK (1995) Calcium-mediated cell injury and cell death. FASEB J 9:219-228.
82. Voth EA, Schwartz RH (1997) Medicinal applications of delta-9-tetrahydrocannabinol and marijuana. Ann Intern Med 126:791-798.
83. 2+ oscillations in HEK-293 cells. J Biol Chem 270:24108-24115.
84. Wei EP, Kontos HA, Dietrich WD, Povlishock JT, Ellis EF (1981) Inhibition by free radical scavengers and by cyclooxygenase inhibitors of pial arteriolar abnormalities from concussive brain injury in cats. Circ Res 48:95-103.
85. Weisskopf MG, Castillo PE, Zalutsky RA, Nicoll RA (1994) Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science 23:1878-1882.
86. Wissing D, Mouritzen H, Egeblad M, Poirier GG, Jaattela M (1997) Involvement of caspase-dependent activation of cytosolic phospholipase A(2) in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci USA 94:5073-5077.
87. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP Kinases on apoptosis. Science 270:1326-1331.
88. Xiang H, Hoch man DW, Saya H, Fujiwara T, Schwartzkroin PA, Morrison RS (1996) Evidence for p53-mediated modulation of neuronal viability. J Neurosci 16:6753-6765.
89. Yamamoto S (1991) Enzymatic lipid peroxidation: reactions of mammalian lipoxygenases. Free Radic Biol Med 10:149-159.